Globus Medical, Inc. Share Price: GMED (Globus Medical, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Globus Medical, Inc. share price today?

Accepted Answer

Globus Medical, Inc. (GMED) share price today is {{live_price}}.

Question 2

Can Indians buy Globus Medical, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Globus Medical, Inc. (GMED) from India.

With INDmoney, you can buy Globus Medical, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Globus Medical, Inc. at zero transaction cost.

Question 3

How can I buy Globus Medical, Inc. shares from India?

Accepted Answer

It is very easy to buy Globus Medical, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Globus Medical, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Globus Medical, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Globus Medical, Inc. stocks?

Accepted Answer

To start investing in Globus Medical, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Globus Medical, Inc.

Accepted Answer

Today’s highest price of Globus Medical, Inc. (GMED) is {{1_rba_end}}.

Today’s lowest price of Globus Medical, Inc. (GMED) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Globus Medical, Inc.

Accepted Answer

Today's market capitalisation of Globus Medical, Inc. GMED is 7.0B

Question 8

What is the 52 Week High and Low Range of Globus Medical, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Globus Medical, Inc. is down from its 52 Week High?

Accepted Answer

Globus Medical, Inc. (GMED) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Globus Medical, Inc. is up from its 52 Week low?

Accepted Answer

Globus Medical, Inc. (GMED) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Globus Medical, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Globus Medical, Inc.

Accepted Answer

Mr. David C. Paul is the current Chief Executive Officer (CEO) of Globus Medical, Inc..

Period	Globus Medical, Inc.
3 Months	-14.59%
6 Months	-12.76%
1 Year	-18.41%
3 Years	1.2%

Market Capitalization	7.0B
Book Value	$19.76
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	2.02
PE Ratio	24.88
PEG Ratio	2.93
Wall Street Target Price	66.36

Profit Margin	18.63%
Operating Margin TTM	22.59%

Return On Assets TTM	7.51%
Return On Equity TTM	11.09%

Revenue TTM	1.1B
Revenue Per Share TTM	10.96
Quarterly Revenue Growth YOY	10.6%
Gross Profit TTM	759.1M
EBITDA	318.5M
Diluted Eps TTM	2.02
Quarterly Earnings Growth YOY	0.08

Globus Medical, Inc. (GMED)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	2.31
EPS Estimate Next Year	2.59
EPS Estimate Current Quarter	0.59
EPS Estimate Next Quarter	0.57

	FY17	Y/Y Change
Revenue	636.0M	↑ 12.76%
Net Income	107.3M	↑ 2.88%
Net Profit Margin	16.88%	↓ 1.62%

	FY18	Y/Y Change
Revenue	713.0M	↑ 12.11%
Net Income	156.5M	↑ 45.76%
Net Profit Margin	21.95%	↑ 5.07%

	FY19	Y/Y Change
Revenue	785.4M	↑ 10.15%
Net Income	155.2M	↓ 0.81%
Net Profit Margin	19.76%	↓ 2.19%

	FY20	Y/Y Change
Revenue	789.0M	↑ 0.47%
Net Income	102.3M	↓ 34.1%
Net Profit Margin	12.96%	↓ 6.8%

	FY21	Y/Y Change
Revenue	958.1M	↑ 21.43%
Net Income	149.2M	↑ 45.86%
Net Profit Margin	15.57%	↑ 2.61%

	FY22	Y/Y Change
Revenue	1.0B	↑ 6.76%
Net Income	190.2M	↑ 27.47%
Net Profit Margin	18.59%	↑ 3.02%

	Q1 FY22	Q/Q Change
Revenue	230.5M	↓ 7.79%
Net Income	38.1M	↑ 152.11%
Net Profit Margin	16.52%	↑ 10.48%

	Q2 FY22	Q/Q Change
Revenue	263.6M	↑ 14.36%
Net Income	54.6M	↑ 43.34%
Net Profit Margin	20.71%	↑ 4.19%

	Q3 FY22	Q/Q Change
Revenue	254.1M	↓ 3.6%
Net Income	47.4M	↓ 13.11%
Net Profit Margin	18.66%	↓ 2.05%

	FY18	Y/Y Change
Total Assets	1.3B	↑ 20.6%
Total Liabilities	115.2M	↑ 4.0%

	FY19	Y/Y Change
Total Assets	1.5B	↑ 17.79%
Total Liabilities	129.6M	↑ 12.57%

	FY20	Y/Y Change
Total Assets	1.7B	↑ 9.62%
Total Liabilities	173.2M	↑ 33.61%

	FY21	Y/Y Change
Total Assets	2.0B	↑ 16.54%
Total Liabilities	215.9M	↑ 24.65%

	Q4 FY22	Q/Q Change
Revenue	274.5M	↑ 8.01%
Net Income	50.1M	↑ 5.55%
Net Profit Margin	18.24%	↓ 0.42%

	Q1 FY23	Q/Q Change
Revenue	276.7M	↑ 0.8%
Net Income	49.1M	↓ 1.87%
Net Profit Margin	17.76%	↓ 0.48%

	Q2 FY23	Q/Q Change
Revenue	291.6M	↑ 5.39%
Net Income	57.7M	↑ 17.47%
Net Profit Margin	19.79%	↑ 2.03%

	FY17	Y/Y Change
Operating Cash Flow	159.5M	↓ 7.19%
Investing Cash Flow	-111.3M	↓ 31.62%
Financing Cash Flow	1.6M	↓ 20.33%

	FY18	Y/Y Change
Operating Cash Flow	181.6M	↑ 13.86%
Investing Cash Flow	-193.0M	↑ 73.47%
Financing Cash Flow	32.6M	↑ 1903.08%

	FY19	Y/Y Change
Operating Cash Flow	172.0M	↓ 5.32%
Investing Cash Flow	-140.3M	↓ 27.33%
Financing Cash Flow	24.4M	↓ 24.96%

	FY20	Y/Y Change
Operating Cash Flow	198.8M	↑ 15.59%
Investing Cash Flow	-117.3M	↓ 16.37%
Financing Cash Flow	-38.7M	↓ 258.2%

	FY21	Y/Y Change
Operating Cash Flow	276.3M	↑ 38.98%
Investing Cash Flow	-375.9M	↑ 220.43%
Financing Cash Flow	54.1M	↓ 240.05%

	FY22	Y/Y Change
Operating Cash Flow	178.5M	↓ 35.4%
Investing Cash Flow	-110.4M	↓ 70.64%
Financing Cash Flow	-110.0M	↓ 303.08%

	Q1 FY22	Q/Q Change
Operating Cash Flow	44.7M	↓ 41.39%
Investing Cash Flow	-13.9M	↓ 94.3%
Financing Cash Flow	6.0M	↓ 691.1%

	Q2 FY22	Q/Q Change
Operating Cash Flow	36.9M	↓ 17.47%
Investing Cash Flow	27.1M	↓ 295.24%
Financing Cash Flow	-142.8M	↓ 2460.87%

	Q3 FY22	Q/Q Change
Operating Cash Flow	32.9M	↓ 10.74%
Investing Cash Flow	-63.1M	↓ 332.66%
Financing Cash Flow	13.2M	↓ 109.22%

	Q4 FY22	Q/Q Change
Operating Cash Flow	64.0M	↑ 94.33%
Investing Cash Flow	-60.5M	↓ 4.16%
Financing Cash Flow	13.6M	↑ 3.26%

	Q1 FY23	Q/Q Change
Operating Cash Flow	53.3M	↓ 16.67%
Investing Cash Flow	11.0M	↓ 118.17%
Financing Cash Flow	2.9M	↓ 78.37%

	Q2 FY23	Q/Q Change
Operating Cash Flow	35.0M	↓ 34.3%
Investing Cash Flow	52.2M	↑ 375.09%
Financing Cash Flow	1.1M	↓ 63.13%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Globus Medical, Inc.	-8.45%	-12.76%	-18.41%	1.2%	-11.47%
Stryker Corporation	-3.93%	-4.97%	30.23%	30.96%	52.96%
Boston Scientific Corp.	-1.53%	6.19%	32.4%	37.43%	35.45%
Edwards Lifesciences Corp.	-9.3%	-15.69%	-18.93%	-12.28%	21.67%
Abbott Laboratories	-5.83%	-4.67%	-2.68%	-10.85%	30.67%
Medtronic Plc	-4.59%	-1.64%	-5.25%	-23.4%	-21.24%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Globus Medical, Inc.	Hold	$7.0B	-11.47%	24.88	18.63%
Stryker Corporation	Buy	$103.8B	52.96%	38.6	13.92%
Boston Scientific Corp.	Buy	$78.1B	35.45%	90.46	6.81%
Edwards Lifesciences Corp.	Buy	$42.5B	21.67%	31.09	24.56%
Abbott Laboratories	Buy	$170.3B	30.67%	33.49	12.83%
Medtronic Plc	Buy	$104.7B	-21.24%	29.04	11.47%

Organization	Globus Medical, Inc.
Employees	2600
CEO	Mr. David C. Paul
Industry	Health Technology